|
aprepitant 125 mg (CAPSULE)
|
$56.3733
|
|
VA NC
|
|
| Aprepitant (6) |
Glenmark Pharmaceuticals, Inc., USA |
|
|
aprepitant 125 mg (POWDER)
|
$252.3700
|
|
VA Big4
|
|
| EMEND (1) |
Merck Sharp & Dohme Corporation |
|
|
aprepitant 125 mg (POWDER)
|
$322.9300
|
|
VA FSS
|
|
| EMEND (1) |
Merck Sharp & Dohme Corporation |
|
|
aprepitant 130 mg / 18 mL (18 mL INJECTION)
|
$195.7600
|
|
VA Big4
|
|
| CINVANTI (1) |
Heron Therapeutics, Inc. |
|
|
aprepitant 130 mg / 18 mL (18 mL INJECTION)
|
$213.4900
|
|
VA FSS
|
|
| CINVANTI (1) |
Heron Therapeutics, Inc. |
|
|
aprepitant 165 mg (CAPSULE)
|
$51.9296
|
|
AUS PBS
|
generic
|
| Aprepitant APOTEX (1) |
Apotex Pty Ltd |
|
|
aprepitant 40 mg (CAPSULE)
|
$11.1140
|
|
VA NC
|
|
| Aprepitant (5) |
Glenmark Pharmaceuticals, Inc., USA |
|
|
aprepitant 40 mg (CAPSULE)
|
$11.1600
|
|
VA NC
|
|
| Aprepitant (1) |
Glenmark Pharmaceuticals, Inc., USA |
|
|
aprepitant 40 mg (CAPSULE)
|
$79.9243
|
|
NADAC
|
generic
|
| APREPITANT (1) |
Torrent Pharmaceuticals Limited |
|
|
aprepitant 40 mg (CAPSULE)
|
$87.8300
|
|
VA Big4
|
|
| EMEND (1) |
Merck Sharp & Dohme Corporation |
|
|
aprepitant 40 mg (CAPSULE)
|
$106.7200
|
|
VA FSS
|
|
| EMEND (1) |
Merck Sharp & Dohme Corporation |
|
|
aprepitant 80 mg (CAPSULE)
|
$32.1250
|
|
VA NC
|
|
| Aprepitant (6) |
Glenmark Pharmaceuticals, Inc., USA |
|
|
aprepitant 80 mg (CAPSULE)
|
$32.2350
|
|
VA NC
|
|
| Aprepitant (2) |
Glenmark Pharmaceuticals, Inc., USA |
|
|
aprepitant 80 mg (CAPSULE)
|
$161.7200
|
|
VA Big4
|
|
| EMEND (2) |
Merck Sharp & Dohme Corporation |
|
|
aprepitant 80 mg (CAPSULE)
|
$197.8600
|
|
VA FSS
|
|
| EMEND (2) |
Merck Sharp & Dohme Corporation |
|
|
fosaprepitant 150 mg / 5 mL (5 mL INJECTION)
|
$0.2837
|
|
VA Big4
|
|
| EMEND (150) |
Merck Sharp & Dohme Corporation |
|
|
fosaprepitant 150 mg / 5 mL (5 mL INJECTION)
|
$1.8831
|
|
VA FSS
|
|
| EMEND (150) |
Merck Sharp & Dohme Corporation |
|
|
fosaprepitant 150 mg / 5 mL (5 mL INJECTION)
|
$87.9400
|
|
VA FSS
|
|
| Fosaprepitant (1) |
Celltrion USA, Inc. |
|
|
fosaprepitant 150 mg / 5 mL (5 mL INJECTION)
|
$120.4500
|
|
VA FSS
|
|
| Fosaprepitant (1) |
Fresenius Kabi, LLC |
|
|
fosaprepitant dimeglumine 150 mg (INJECTION)
|
$64.4300
|
|
VA Big4
|
|
| Fosaprepitant (1) |
Teva Pharmaceuticals USA, Inc. |
|
|
fosaprepitant dimeglumine 150 mg (INJECTION)
|
$71.0300
|
|
VA FSS
|
|
| Fosaprepitant (1) |
Teva Pharmaceuticals USA, Inc. |
|
|
fosaprepitant dimeglumine 150 mg (INJECTION)
|
$80.9956
|
|
AUS PBS
|
generic
|
| Emend IV (1) |
Merck Sharp & Dohme (Australia) Pty Ltd |
|
